These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3705518)

  • 41. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Age-related characteristics of the manifestation of the diabetogenic factor in the blood of animals maintained on natural and atherogenic diets].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG; Pytel' IuA
    Probl Endokrinol (Mosk); 1984; 30(2):65-70. PubMed ID: 6718336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA; Pastorova VE; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The indices of the function of the anticoagulation system and of the nonenzymatic fibrinolytic activity of the antithrombin III-heparin-thrombin complex in the blood of children with burn and traumatic shock].
    Pastorova VE; Liapina LA; Tabakina TE
    Fiziol Cheloveka; 1990; 16(2):71-6. PubMed ID: 2373319
    [No Abstract]   [Full Text] [Related]  

  • 45. [Characteristics of nonenzymatic fibrinolytic activity and the formation of adrenaline-heparin and noradrenaline-heparin complexes in the blood in logoneurosis].
    Podol'skaia OV; Shklovskii VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):711-5. PubMed ID: 4718614
    [No Abstract]   [Full Text] [Related]  

  • 46. [Mechanism of inhibition of non-enzymatic fibrinolysis by a spleen factor].
    Liapina LA; Azieva LD
    Biokhimiia; 1985 Jan; 50(1):69-73. PubMed ID: 3978152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombin generation and neutralization test (TGNT) - a simple, practical, and sensitive assay for plasma heparin quantitation.
    Stavridis IC; Vorias NI
    Thromb Haemost; 1978 Jun; 39(3):631-9. PubMed ID: 705692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Physiologic properties of heparin--thromboplastin complex].
    Kudriashov BA; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):771-6. PubMed ID: 680264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The toxic action of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes].
    Kudriashov BA
    Izv Akad Nauk Ser Biol; 1993; (5):694-702. PubMed ID: 8220079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Decreased sensitivity to the hypoglycemic action of insulin in animals with a lowered blood heparin concentration].
    Ul'ianov AM; Shapiro FB; Bazaz'ian GG
    Biull Eksp Biol Med; 1987 May; 103(5):522-4. PubMed ID: 3297185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coagulation protein function: the influence of acetaldehyde-modified heparin on thrombin activity.
    Brecher AS; Fu Q
    J Investig Med; 1999 Jan; 47(1):76-80. PubMed ID: 10071484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity.
    Kato Y; Liu KX; Nakamura T; Sugiyama Y
    Hepatology; 1994 Aug; 20(2):417-24. PubMed ID: 8045504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV
    Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis].
    Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA
    Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Insulin-heparin complex, its physiological properties].
    Kudriashov BA; Pytel' IuA; Liapina LA; Baskakova GM
    Vopr Med Khim; 1981; 27(4):547-52. PubMed ID: 7027617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.